hormone receptor-positive breast cancer
GPTKB entity
Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:can_detect |
mammography
|
| gptkbp:can_lead_to |
metastatic breast cancer
|
| gptkbp:caused_by |
long-term hormone replacement therapy
|
| gptkbp:diagnosis |
biopsy
|
| gptkbp:has_type |
gptkb:estrogen_receptor-positive_breast_cancer
gptkb:progesterone_receptor-positive_breast_cancer |
| https://www.w3.org/2000/01/rdf-schema#label |
hormone receptor-positive breast cancer
|
| gptkbp:is_affected_by |
lifestyle factors
hormone levels |
| gptkbp:is_associated_with |
gptkb:tamoxifen
obesity psychosocial impacts increased risk of recurrence aromatase inhibitors higher survival rates |
| gptkbp:is_characterized_by |
the presence of hormone receptors
|
| gptkbp:is_common_in |
postmenopausal women
African American women younger women |
| gptkbp:is_considered |
a significant health issue
a major subtype of breast cancer a subtype of invasive breast cancer |
| gptkbp:is_evaluated_by |
oncologists
pathologists |
| gptkbp:is_influenced_by |
genetic factors
|
| gptkbp:is_linked_to |
support groups
hormonal imbalances alcohol consumption radiation exposure socioeconomic factors hormonal therapies patient education programs dietary factors physical inactivity family history of breast cancer age at first menstruation age at menopause |
| gptkbp:is_monitored_by |
regular imaging tests
|
| gptkbp:is_part_of |
breast cancer awareness campaigns
breast cancer treatment guidelines breast cancer research initiatives breast cancer classification |
| gptkbp:is_studied_for |
new treatment options
|
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:is_subject_to |
research studies
|
| gptkbp:occurs_in |
both men and women
|
| gptkbp:requires |
gptkb:surgery
|
| gptkbp:scientific_classification |
hormone-sensitive cancer
|
| gptkbp:treatment |
radiation therapy
chemotherapy targeted therapy hormonal therapy |
| gptkbp:bfsParent |
gptkb:Verzenio
gptkb:Faslodex |
| gptkbp:bfsLayer |
5
|